RCRI overestimated 30-day cardiac risk in transurethral prostate surgery, while NSQIP predictions matched observed cardiac event rates, aiding better risk stratification.
Do preoperative cardiac risk calculators (RCRI vs NSQIP) accurately predict 30-day cardiac events in patients undergoing transurethral prostate surgery?
The NSQIP predictive tool provides a more accurate estimation of 30-day cardiac risk compared to the RCRI for patients undergoing transurethral prostate surgery.
Tasa de eventos absoluta: 0% vs 0%
The RCRI significantly overestimated the 30-day cardiac risk after transurethral prostate surgery, whereas NSQIP predictions and the observed rate of cardiac events were similar. Utilizing more representative predictive tools helps improve risk stratification and will allow patients and surgeons to make better-informed decisions.
Saffarzadeh et al. (Wed,) reported a other. RCRI overestimated 30-day cardiac risk in transurethral prostate surgery, while NSQIP predictions matched observed cardiac event rates, aiding better risk stratification.